Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening,diagnosis, and evaluation of early gastric cancer |
| |
| Authors: | Zengbao Lin Huiqin Bian Chaoyuan Chen Wenling Chen Qiong Li |
| |
| Affiliation: | 1.Department of Digestive Endoscopy, the Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China;2.Department of Traditional Medicine, the Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China;3.Department of Preventive Treatment, the Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China |
| |
| Abstract: | BackgroundGastric cancer is a common malignant tumor. The aim of the present study was to analyze the application value of serum pepsinogen (PG), carbohydrate antigen 72-4 (CA72-4), and gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer.MethodsIn total, 122 patients with gastric cancer treated in our hospital from January 2018 to January 2021 were selected as the gastric cancer group and subdivided into the early gastric cancer (group A) and advanced gastric cancer (group B) groups. Sixty-five patients with benign gastric disease treated in the same hospital during the same period were selected as the control group, and 122 healthy people who underwent physical examination during the same period were allocated to the control group. The differences in the levels of G-17, PGI, PGII, PGI/PGII, and CA72-4 were compared; receiver-operating characteristic curves were drawn; and the efficacy of different factors in the diagnosis of early gastric cancer was calculated.ResultsG-17, PGI, and PGI/PGII levels in the gastric cancer group were significantly lower than those in the healthy group, and CA72-4 was significantly higher than that in the healthy group (P<0.05), but there was no significant difference in PGII between the 2 groups (P>0.05). G-17, PGI, and PGI/PGII levels in groups A and B were significantly lower than those in the control group. CA72-4 in groups A and B was significantly higher than that of the control group, and was highest in group B (P<0.05). The areas under the curve (AUC) of G-17, PGI, PGI/PGII, and CA72-4 were 0.671, 0.726, 0.769, and 0.602, respectively, and the AUC of combined detection was 0.883, which was significantly higher than that of single detection.ConclusionsSerum PG, CA72-4 combined with G-17 detection has high sensitivity and specificity in the screening and diagnosis of early gastric cancer, and has high clinical application value. |
| |
| Keywords: | Serum pepsinogen (serum PG) carbohydrate antigen 72-4 (CA72-4) gastrin-17 (G-17) gastric cancer screening early gastric cancer |
|
|
